3D Medicines Inc. Shifts Focus to NSCLC Trial

TipRanksDec 19 10:08 ET

Is 3D Medicines (HKG:1244) Using Too Much Debt?

Simply Wall StDec 12 18:30 ET

3D MEDICINES: Interim Report 2024

HKEXSep 27 04:41 ET · Announcements

Hong Kong Stock Market Surges | Sino-Biopharmaceutical Limited (01244) fell more than 15% to a new low, with a total market value of less than 0.6 billion Hong Kong dollars. The company has been excluded from the Hong Kong Stock Connect.

Citic Pharma (01244) fell more than 15%, hitting a new low of HK$2.31 since its listing, with a current market cap of only HK$0.599 billion, evaporating more than HK$33 billion from its peak.

Zhitong FinanceSep 11 03:30 ET

Sino Biopharmaceutical Limited (01244) fell 58.90%, now at 2.960 yuan, hitting a new 52-week low.

As of 11:47, Si Lu Di Pharmaceutical (01244) fell 58.90% from the previous closing price and is now trading at HKD 2.960, hitting a 52-week low. The volume of transactions was 0.3215 million shares, with a turnover of HKD 0.9347 million.

金吾財訊Sep 8 23:47 ET

3D Medicines Executives Bolster Shareholdings

TipRanksSep 4 10:38 ET